Delcath Reports on 2005 Annual Meeting
June 15, 2005 11:46 ET | Delcath Systems
STAMFORD, Conn., June 15, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) reported shareholders attending the company's 2005 annual meeting voted in favor of the re-election of Samuel...
Mid-Year 2005 Letter to Delcath Shareholders
June 09, 2005 08:45 ET | Delcath Systems
STAMFORD, Conn., June 9, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH): Mid-Year Report To Our Stockholders: I am sure most of you are aware of the recent notice we received from the...
NCI'S Report on Initial Study of Delcath System in Current Issue of Journal of Clinical Oncology
May 24, 2005 08:29 ET | Delcath Systems
STAMFORD, Conn., May 24, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said results of the National Cancer Institute's study of the company's system for delivering high-dose chemotherapy...
Delcath Receives Fast-Track Status from U.S. FDA for High Dose Cancer Treatment with Melphalan
May 11, 2005 11:04 ET | Delcath Systems
STAMFORD, Conn., May 11, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said its novel system for delivering high dose chemotherapy to specific organs and body regions received fast-track...